文献
J-GLOBAL ID:202102230735998671
整理番号:21A0898355
iKIR-HLA C対の減少は,抗胸腺細胞グロブリンベースの半数体造血幹細胞移植を受ける骨髄疾患患者の予後不良をもたらす【JST・京大機械翻訳】
Decreased iKIR-HLA C Pair Confers Worse Clinical Outcomes for Patients With Myeloid Disease Receiving Antithymocyte Globulin-Based Haploidentical Hematopoietic Stem Cell Transplantation
著者 (31件):
Zhao Yanmin
(1Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Zhao Yanmin
(2Institute of Hematology, Zhejiang University, Hangzhou, China)
,
Zhao Yanmin
(3Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China)
,
Gao Fei
(1Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Gao Fei
(2Institute of Hematology, Zhejiang University, Hangzhou, China)
,
Gao Fei
(3Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China)
,
Wu Yibo
(1Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Wu Yibo
(2Institute of Hematology, Zhejiang University, Hangzhou, China)
,
Wu Yibo
(3Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China)
,
Shi Jimin
(1Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Shi Jimin
(2Institute of Hematology, Zhejiang University, Hangzhou, China)
,
Shi Jimin
(3Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China)
,
Luo Yi
(1Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Luo Yi
(2Institute of Hematology, Zhejiang University, Hangzhou, China)
,
Luo Yi
(3Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China)
,
Tan Yamin
(1Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Tan Yamin
(2Institute of Hematology, Zhejiang University, Hangzhou, China)
,
Tan Yamin
(3Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China)
,
Yu Jian
(1Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Yu Jian
(2Institute of Hematology, Zhejiang University, Hangzhou, China)
,
Yu Jian
(3Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China)
,
Lai Xiaoyu
(1Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Lai Xiaoyu
(2Institute of Hematology, Zhejiang University, Hangzhou, China)
,
Lai Xiaoyu
(3Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China)
,
Zhang Mingming
(1Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Zhang Mingming
(2Institute of Hematology, Zhejiang University, Hangzhou, China)
,
Zhang Mingming
(3Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China)
,
Zhang Wei
(4Zhejiang Blood Center, Hangzhou, China)
,
Huang He
(1Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)
,
Huang He
(2Institute of Hematology, Zhejiang University, Hangzhou, China)
,
Huang He
(3Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China)
資料名:
Frontiers in Immunology (Web)
(Frontiers in Immunology (Web))
巻:
11
ページ:
614488
発行年:
2020年
JST資料番号:
U7074A
ISSN:
1664-3224
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)